98 related articles for article (PubMed ID: 12111253)
1. Cardiac microtubules are more resistant to chemical depolymerisation in streptozotocin-induced diabetes in the rat.
Howarth FC; Qureshi MA; White E; Calaghan SC
Pflugers Arch; 2002 Jun; 444(3):432-7. PubMed ID: 12111253
[TBL] [Abstract][Full Text] [Related]
2. Stable microtubules contribute to cardiac dysfunction in the streptozotocin-induced model of type 1 diabetes in the rat.
Shiels H; O'Connell A; Qureshi MA; Howarth FC; White E; Calaghan S
Mol Cell Biochem; 2007 Jan; 294(1-2):173-80. PubMed ID: 16838107
[TBL] [Abstract][Full Text] [Related]
3. Effects of hyperosmotic shrinking on ventricular myocyte shortening and intracellular Ca(2+) in streptozotocin-induced diabetic rats.
Howarth FC; Qureshi MA; White E
Pflugers Arch; 2002 Jun; 444(3):446-51. PubMed ID: 12111255
[TBL] [Abstract][Full Text] [Related]
4. Effects of brain natriuretic peptide on contraction and intracellular Ca2+ in ventricular myocytes from the streptozotocin-induced diabetic rat.
Howarth FC; Al-Shamsi N; Al-Qaydi M; Al-Mazrouei M; Qureshi A; Chandranath SI; Kazzam E; Adem A
Ann N Y Acad Sci; 2006 Nov; 1084():155-65. PubMed ID: 17151299
[TBL] [Abstract][Full Text] [Related]
5. An estrogen metabolite, 2-methoxyestradiol, disrupts cardiac microtubules and unmasks muscarinic inhibition of calcium current.
Shen JB; Pappano AJ
J Pharmacol Exp Ther; 2008 May; 325(2):507-12. PubMed ID: 18276848
[TBL] [Abstract][Full Text] [Related]
6. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes.
Norby FL; Wold LE; Duan J; Hintz KK; Ren J
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E658-66. PubMed ID: 12217882
[TBL] [Abstract][Full Text] [Related]
7. Effects of streptozotocin-induced diabetes on contraction and calcium transport in rat ventricular cardiomyocytes.
Bracken N; Howarth FC; Singh J
Ann N Y Acad Sci; 2006 Nov; 1084():208-22. PubMed ID: 17151303
[TBL] [Abstract][Full Text] [Related]
8. Changes in expression of adrenomedullin in the myocardium of streptozotocin-induced diabetic rats.
He RX; Gu CL; Shen F; Zhang XM
Chin Med J (Engl); 2007 Feb; 120(3):187-91. PubMed ID: 17355819
[TBL] [Abstract][Full Text] [Related]
9. Dyssynchronous (non-uniform) Ca2+ release in myocytes from streptozotocin-induced diabetic rats.
Shao CH; Rozanski GJ; Patel KP; Bidasee KR
J Mol Cell Cardiol; 2007 Jan; 42(1):234-46. PubMed ID: 17027851
[TBL] [Abstract][Full Text] [Related]
10. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats.
Soliman H; Craig GP; Nagareddy P; Yuen VG; Lin G; Kumar U; McNeill JH; Macleod KM
Cardiovasc Res; 2008 Jul; 79(2):322-30. PubMed ID: 18411229
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of adenosine receptors in heart of diabetic rat.
Grdeń M; Podgórska M; Szutowicz A; Pawełczyk T
J Physiol Pharmacol; 2005 Dec; 56(4):587-97. PubMed ID: 16391416
[TBL] [Abstract][Full Text] [Related]
12. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
[TBL] [Abstract][Full Text] [Related]
13. Expression changes of mitogen-activated protein kinase phosphatase-1 (MKP-1) in myocardium of streptozotocin-induced diabetic rats.
Weng Y; Shen F; Li J; Shen Y; Zhang X
Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):455-60. PubMed ID: 17647144
[TBL] [Abstract][Full Text] [Related]
14. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation.
Wang J; Song Y; Elsherif L; Song Z; Zhou G; Prabhu SD; Saari JT; Cai L
Circulation; 2006 Jan; 113(4):544-54. PubMed ID: 16432057
[TBL] [Abstract][Full Text] [Related]
15. Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats.
Yu BC; Chang CK; Ou HY; Cheng KC; Cheng JT
Cardiovasc Res; 2008 Oct; 80(1):78-87. PubMed ID: 18573863
[TBL] [Abstract][Full Text] [Related]
16. Defective phosphatidic acid-phospholipase C signaling in diabetic cardiomyopathy.
Tappia PS; Maddaford TG; Hurtado C; Dibrov E; Austria JA; Sahi N; Panagia V; Pierce GN
Biochem Biophys Res Commun; 2004 Mar; 316(1):280-9. PubMed ID: 15003542
[TBL] [Abstract][Full Text] [Related]
17. The cardiac neural stem cell phenotype is compromised in streptozotocin-induced diabetic cardiomyopathy.
El-Helou V; Proulx C; Béguin P; Assimakopoulos J; Gosselin H; Clement R; Villeneuve L; Huot-Marchand JE; Deblois D; Lajoie C; Calderone A
J Cell Physiol; 2009 Aug; 220(2):440-9. PubMed ID: 19388005
[TBL] [Abstract][Full Text] [Related]
18. Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice.
Wang Y; Ebermann L; Sterner-Kock A; Wika S; Schultheiss HP; Dörner A; Walther T
Exp Physiol; 2009 Feb; 94(2):220-7. PubMed ID: 18945756
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Ca(2+) signaling by microtubule disruption in rat ventricular myocytes and its dependence on the ruptured patch-clamp configuration.
Calaghan SC; Le Guennec JY; White E
Circ Res; 2001 Mar; 88(4):E32-7. PubMed ID: 11230115
[TBL] [Abstract][Full Text] [Related]
20. [Changes in diameter size and F-actin expression in the myocytes of patients with diabetes and streptozotocin-induced diabetes model rats].
Kawaguchi M; Asakura T; Saito F; Nemoto O; Maehara K; Miyake K; Sugai N; Maruyama Y
J Cardiol; 1999 Dec; 34(6):333-9. PubMed ID: 10642930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
